Biomarin Pharmaceutical (bmrn 0.599 08/01/24)
13F holders, Q2 2024 (June 30)8holders −6
1new positions
7sold out
$0.99avg. 13F price*
At the end of Q2 2024, 8 institutions reported holding Biomarin Pharmaceutical (bmrn 0.599 08/01/24) in their 13F filings, down 6 from Q1 2024. 1 opened new positions and 7 sold out. The largest holders were Truist Financial Corp. ($9.9M), Sonora Investment Management Group, LLC ($6.0M) and Jane Street Group, LLC ($2.5M).
- Company
- Biomarin Pharmaceutical (bmrn 0.599 08/01/24)
- CUSIP
- 09061GAH4
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $5K |
| Exits | 7 | $101.1M |
All 13F filers, Q1 2024 → Q2 2024: 8,051,000 shares bought and 64,179,775 shares sold, net −56,128,775 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Truist Financial Corp. | 0.02% | Add +411.8% | 10,000,000 | $9.9M |
| Sonora Investment Management Group, LLC | 0.47% | No change | 6,085,000 | $6.0M |
| Jane Street Group, LLC | 0.00% | No change | 2,575,000 | $2.5M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | Reduce -71.4% | 1,000,000 | $990K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 32,000 | $32K |
| Prudent Investors Network, Inc. | 0.00% | No change | 12,000 | $12K |
| Fox Hill Wealth Management | 0.01% | No change | 11,000 | $11K |
| Rothschild Investment LLC | 0.00% | New | 5,000 | $5K |
"% of holder's portfolio" is BIOMARIN PHARMACEUTICAL (BMRN 0.599 08/01/24)'s weight in each manager's 13F, not the share of Biomarin Pharmaceutical (bmrn 0.599 08/01/24) the manager owns.